Data search
Results for MligTC455_17513
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_17513 | 513 | 10.68 | Mlig455_044710 | Neo: - |
Mlig455_044710 {REF} {Length: 1090} {RNA1509_54502} {RNA1310_19892.1} {RNA815_10608} |
Cumulative graph for MligTC455_17513
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.89 | 3.645 | 0.56860 | 1.00000 | |
| RegionR2 | 0.192 | 3.645 | 0.80740 | 1.00000 | |
| RegionR3 | -0.158 | 3.645 | 0.81853 | 1.00000 | |
| RegionR4 | 0.051 | 3.645 | 0.94648 | 1.00000 | |
| RegionR5 | -0.073 | 3.645 | 0.91054 | 1.00000 | |
| RegionR6 | 0.164 | 3.645 | 0.80404 | 1.00000 | |
| RegionR7 | -0.698 | 3.645 | 0.41505 | 1.00000 | |
| RegionR8 | 1.412 | 3.645 | 0.06356 | 0.48992 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -6.139 | 3.645 | 0.23286 | 0.96237 | |
| RegenerationR2 | 0.899 | 3.645 | 0.21613 | 0.66327 | |
| RegenerationR3 | 0.446 | 3.645 | 0.57634 | 0.89712 | |
| RegenerationR4 | 0.014 | 3.645 | 0.98480 | 1.00000 | |
| RegenerationR5 | 0.453 | 3.645 | 0.54950 | 0.88559 | |
| RegenerationR6 | 0.352 | 3.645 | 0.66248 | 0.90475 | |
| RegenerationBL | 0.592 | 3.645 | 0.42022 | 0.78861 | |
| RegenerationTP | 0.934 | 3.645 | 0.23045 | 0.67540 |
Genes with expression patterns similar to MligTC455_17513
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_17513 | 513 | 10.68 | Mlig455_044710 | Neo: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_044710 {REF} {Length: 1090} {RNA1509_54502} {RNA1310_19892.1} {RNA815_10608} | |
| 2. | MligTC455_14738 | 140 | 2.92 | Mlig455_044382 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.555 Region-enriched R8: 3.007/0.01820 |
BMP2 | 2.505 | 0.953 | - | 0.730 | - | - | 0.822 | Mlig455_044382 {REF} {Length: 3994} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=102.6]; TGF-beta propeptide [PF00688.20, score=57.9]} {Human: ENSG00000125845, BMP2, bone morphogenetic protein 2, [RH, Score=156, Expect=5e-43]; ENSG00000125378, BMP4, bone morphogenetic protein 4, [RH, Score=149, Expect=4e-40]} {Mouse: ENSMUSG00000027358, Bmp2, bone morphogenetic protein 2, [RH, Score=159, Expect=3e-44]} {Dmel: FBgn0000490, dpp, decapentaplegic, [RH, Score=142, Expect=5e-37]} {Celegans: WBGene00000936, dbl-1, DPP/BMP-Like; Decapentaplegic protein homolog, [Score=114, Expect=4e-28]} {Smed: dd_Smed_v6_12939_2_1, dd_Smed_v6_12939_2_1, [RH, Score=228, Expect=7e-70]} {RNA1310_15976.1} {RNA815_13484} |
| 3. | MligTC455_35478 | 597 | 12.43 | Mlig455_020720, Mlig455_020788 | Neo: - Age: logFC(26M/2M)=0.408 |
1.881 | - | - | 0.926 | - | - | 0.955 | Mlig455_020720 {REF} {Length: 1135} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_13719} {RNA1310_25325} {RNA815_14669} Mlig455_020788 {REF} {Length: 1139} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_13719} {RNA1310_25325} {RNA815_14669} |
|
| 4. | MligTC455_51902 | 1049 | 21.85 | Mlig455_021705 | Neo: - Age: logFC(26M/2M)=-0.488 |
CHRNB3 | 1.75 | - | - | - | 0.962 | - | 0.788 | Mlig455_021705 {REF} {Length: 1861} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.7]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=191, Expect=2e-55]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=189, Expect=2e-54]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=182, Expect=6e-52]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=186, Expect=2e-53]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=185, Expect=2e-53]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=182, Expect=4e-52]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=177, Expect=2e-49]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=174, Expect=7e-49]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=347, Expect=6e-116]} {RNA1509_8724} {RNA1310_17144.1} {RNA815_6285} |
| 5. | MligTC455_43120 | 247 | 5.15 | Mlig455_025263 | Neo: - Age: Up-Down-Down |
1.712 | - | - | - | 0.747 | - | 0.965 | Mlig455_025263 {REF} {Length: 4290} {RNA1509_20151} {RNA1310_8688.1} {RNA815_9458.1} | |
| 6. | MligTC455_44864 | 453 | 9.44 | Mlig455_027405 | Neo: - Age: - |
MTUS2 | 1.704 | - | - | - | 0.956 | - | 0.748 | Mlig455_027405 {REF} {Length: 8444} {TRANSSPLICED} {Human: ENSG00000132938, MTUS2, microtubule associated scaffold protein 2, [Score=58.9, Expect=4e-08]} {Mouse: ENSMUSG00000029651, Mtus2, microtubule associated tumor suppressor candidate 2, [Score=55.8, Expect=2e-07]} {RNA1509_16237, RNA1509_25613, RNA1509_46083, RNA1509_49376, RNA1509_51116} {RNA1310_3116, RNA1509_16237, RNA1509_25613, RNA1509_46083, RNA1509_49376, RNA1509_51116} {RNA1509_16237, RNA1509_25613, RNA1509_46083, RNA1509_49376, RNA1509_51116, RNA815_3763.1} |
| 7. | MligTC455_46564 | 403 | 8.4 | Mlig455_040238 | Neo: - Age: - |
1.683 | - | - | 0.731 | - | - | 0.952 | Mlig455_040238 {REF} {Length: 3013} {RNA1509_9486} {RNA1310_9854} {RNA815_15545} | |
| 8. | MligTC455_36332 | 4005 | 83.44 | Mlig455_035242, Mlig455_035287 | Neo: - |
PIM1 | 0.979 | - | - | - | - | - | 0.979 | Mlig455_035242 {REF} {Length: 2797} {Pfam: Protein kinase domain [PF00069.27, score=193.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=74.5]; Kinase-like [PF14531.8, score=19.8]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.7]} {Human: ENSG00000137193, PIM1, Pim-1 proto-oncogene, serine/threonine kinase, [RH, Score=296, Expect=6e-98]} {Mouse: ENSMUSG00000024014, Pim1, proviral integration site 1, [RH, Score=296, Expect=4e-98]} {Dmel: FBgn0034950, Pask, PAS kinase, [Score=136, Expect=2e-34]} {Celegans: WBGene00004183, prk-2, Serine/threonine-protein kinase prk-2, [RH, Score=228, Expect=2e-70]} {Smed: dd_Smed_v6_4012_0_1, dd_Smed_v6_4012_0_1, [RH, Score=283, Expect=3e-92]} {RNA1509_4124} {RNA1310_8145, RNA1509_4124} {RNA1509_4124, RNA815_2413} Mlig455_035287 {REF} {Length: 2796} {Pfam: Protein kinase domain [PF00069.27, score=193.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=74.5]; Kinase-like [PF14531.8, score=19.8]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.7]} {Human: ENSG00000137193, PIM1, Pim-1 proto-oncogene, serine/threonine kinase, [RH, Score=296, Expect=7e-98]} {Mouse: ENSMUSG00000024014, Pim1, proviral integration site 1, [RH, Score=296, Expect=5e-98]} {Dmel: FBgn0034950, Pask, PAS kinase, [Score=136, Expect=2e-34]} {Celegans: WBGene00004183, prk-2, Serine/threonine-protein kinase prk-2, [RH, Score=226, Expect=1e-69]} {Smed: dd_Smed_v6_4012_0_1, dd_Smed_v6_4012_0_1, [RH, Score=283, Expect=3e-92]} {RNA1509_4124, RNA1509_53578} {RNA1310_8145, RNA1509_53578} {RNA1509_53578, RNA815_2413} |
| 9. | MligTC455_51704 | 158 | 3.29 | Mlig455_051585 | Neo: - Age: - |
EAF1 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_051585 {REF} {Length: 1822} {TRANSSPLICED} {Pfam: RNA polymerase II transcription elongation factor [PF09816.11, score=53.4]} {Human: ENSG00000144597, EAF1, ELL associated factor 1, [Score=87.0, Expect=2e-20]} {Mouse: ENSMUSG00000021890, Eaf1, ELL associated factor 1, [Score=87.0, Expect=1e-20]} {Dmel: FBgn0033166, Eaf, ELL-associated factor, [Score=68.2, Expect=2e-13]} {Smed: dd_Smed_v6_6643_0_1, dd_Smed_v6_6643_0_1, [Score=71.2, Expect=2e-15]} {RNA1509_52015} {RNA1310_64746} {RNA815_8303} |
| 10. | MligTC455_12510 | 323 | 6.72 | Mlig455_038484, Mlig455_052307 | Neo: - Age: Down-Up-Up |
0.966 | - | - | - | 0.966 | - | - | Mlig455_038484 {REF} {Length: 1308} {RNA1310_25487.2} {RNA815_10689} Mlig455_052307 {REF} {Length: 1483} {RNA1509_18097} {RNA1310_25487.2} {RNA815_10689} |
|
| 11. | MligTC455_27425 | 187 | 3.89 | Mlig455_047152 | Neo: - Age: logFC(26M/2M)=0.348 Region-enriched R5: 2.140/0.00643 |
CTDSP1 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_047152 {REF} {Length: 5508} {Pfam: NLI interacting factor-like phosphatase [PF03031.20, score=152.4]} {Human: ENSG00000144579, CTDSP1, CTD small phosphatase 1, [RH, Score=232, Expect=1e-73]; ENSG00000144677, CTDSPL, CTD small phosphatase like, [RH, Score=228, Expect=1e-71]; ENSG00000175215, CTDSP2, CTD small phosphatase 2, [RH, Score=222, Expect=1e-69]} {Mouse: ENSMUSG00000026176, Ctdsp1, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1, [RH, Score=232, Expect=1e-73]; ENSMUSG00000047409, Ctdspl, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like, [RH, Score=229, Expect=3e-72]; ENSMUSG00000078429, Ctdsp2, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2, [RH, Score=224, Expect=1e-70]} {Dmel: FBgn0036556, CG5830, [RH, Score=221, Expect=8e-69]} {Celegans: WBGene00007054, scpl-1, CTD small phosphatase-like protein 1, [RH, Score=223, Expect=2e-67]} {Smed: dd_Smed_v6_8196_0_1, dd_Smed_v6_8196_0_1, [RH, Score=245, Expect=4e-74]} {RNA1509_41690} {RNA1310_6011.1} {RNA815_20170.1} |
| 12. | MligTC455_50148 | 595 | 12.39 | Mlig455_006502, Mlig455_006621 | Neo: - Age: - Region-enriched R4: 1.783/0.00382 |
ZBBX | 0.96 | - | - | - | - | - | 0.960 | Mlig455_006502 {REF} {Length: 3171} {TRANSSPLICED} {Pfam: Cytoplasmic polyadenylation element-binding protein ZZ domain [PF16366.7, score=18.8]} {Human: ENSG00000169064, ZBBX, zinc finger B-box domain containing, [RH, Score=78.6, Expect=3e-14]} {Mouse: ENSMUSG00000034151, Zbbx, zinc finger, B-box domain containing, [RH, Score=89.4, Expect=6e-18]} {Smed: dd_Smed_v6_11048_0_1, dd_Smed_v6_11048_0_1, [RH, Score=139, Expect=3e-34]} {RNA1509_10989, RNA1509_54948} {RNA1310_3743, RNA1509_10989, RNA1509_54948} {RNA1509_10989, RNA1509_54948, RNA815_5872} Mlig455_006621 {REF} {Length: 3128} {TRANSSPLICED} {Human: ENSG00000169064, ZBBX, zinc finger B-box domain containing, [RH, Score=80.1, Expect=9e-15]} {Mouse: ENSMUSG00000034151, Zbbx, zinc finger, B-box domain containing, [RH, Score=89.0, Expect=9e-18]} {Smed: dd_Smed_v6_11048_0_1, dd_Smed_v6_11048_0_1, [RH, Score=139, Expect=3e-34]} {RNA1509_10989} {RNA1310_3743} {RNA815_5872} |
| 13. | MligTC455_23143 | 413 | 8.6 | Mlig455_008087 | Neo: - Age: - Region-enriched R2: 2.201/0.04155 |
INSR | 0.958 | - | - | - | - | - | 0.958 | Mlig455_008087 {REF} {Length: 5415} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.7]; Protein kinase domain [PF00069.27, score=128.3]; Receptor L domain [PF01030.26, score=118.3]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=43.3]; Growth factor receptor domain IV [PF14843.8, score=19.7]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=9e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=477, Expect=6e-141]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=516, Expect=7e-158]} {RNA1509_32205, RNA1509_5152} {RNA1310_762.1, RNA1509_32205, RNA1509_5152} {RNA1509_32205, RNA1509_5152, RNA815_285.1} |
| 14. | MligTC455_52162 | 893 | 18.6 | Mlig455_000693, Mlig455_000751 | Neo: - Age: Down-Up-Down |
FAM177A1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_000693 {REF} {Length: 1193} {TRANSSPLICED} {Pfam: FAM177 family [PF14774.8, score=96.9]} {Human: ENSG00000151327, FAM177A1, family with sequence similarity 177 member A1, [RH, Score=82.8, Expect=2e-19]} {Mouse: ENSMUSG00000094103, 1700047I17Rik2, RIKEN cDNA 1700047I17 gene 2, [RH, Score=82.8, Expect=1e-19]; ENSMUSG00000095595, Fam177a, family with sequence similarity 177, member A, [RH, Score=82.8, Expect=1e-19]} {Dmel: FBgn0029937, CG8300, [RH, Score=58.9, Expect=5e-11]} {Smed: dd_Smed_v6_3285_0_1, dd_Smed_v6_3285_0_1, [RH, Score=53.5, Expect=5e-10]} {RNA1509_25216, RNA1509_31337} {RNA1310_23587.2, RNA1509_31337} {RNA1509_31337, RNA815_25202} Mlig455_000751 {REF} {Length: 1192} {TRANSSPLICED} {Pfam: FAM177 family [PF14774.8, score=97.6]} {Human: ENSG00000151327, FAM177A1, family with sequence similarity 177 member A1, [RH, Score=82.8, Expect=2e-19]} {Mouse: ENSMUSG00000094103, 1700047I17Rik2, RIKEN cDNA 1700047I17 gene 2, [RH, Score=82.4, Expect=1e-19]; ENSMUSG00000095595, Fam177a, family with sequence similarity 177, member A, [RH, Score=82.4, Expect=1e-19]} {Dmel: FBgn0029937, CG8300, [RH, Score=58.9, Expect=5e-11]} {Smed: dd_Smed_v6_3285_0_1, dd_Smed_v6_3285_0_1, [RH, Score=53.5, Expect=5e-10]} {RNA1509_25216, RNA1509_40945, RNA1509_41307} {RNA1310_23587.2, RNA1509_25216, RNA1509_40945, RNA1509_41307} {RNA1509_25216, RNA1509_40945, RNA1509_41307, RNA815_25202} |
| 15. | MligTC455_20956 | 77 | 1.6 | Mlig455_008761 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.712/0.03504 |
GLRA3 | 0.955 | 0.955 | - | - | - | - | - | Mlig455_008761 {REF} {Length: 3739} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=146.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=124.8]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=344, Expect=7e-114]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=2e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=5e-113]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=336, Expect=7e-111]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=291, Expect=2e-93]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [RH, Score=256, Expect=7e-80]} {Smed: dd_Smed_v6_10794_0_1, dd_Smed_v6_10794_0_1, [Score=253, Expect=1e-78]} {RNA1310_38552.1} {RNA815_6481} |
| 16. | MligTC455_50202 | 378 | 7.87 | Mlig455_040081 | Neo: - Age: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_040081 {REF} {Length: 5393} {TRANSSPLICED} {Pfam: MyTH4 domain [PF00784.19, score=60.8]} {Mouse: ENSMUSG00000022272, Myo10, myosin X, [Score=53.5, Expect=1e-06]} {Smed: dd_Smed_v6_19214_0_1, dd_Smed_v6_19214_0_1, [RH, Score=182, Expect=6e-49]} {RNA1509_21521, RNA1509_38698} {RNA1310_14460, RNA1509_21521, RNA1509_38698} {RNA1509_21521, RNA1509_38698, RNA815_19524} | |
| 17. | MligTC455_51903 | 1283 | 26.73 | Mlig455_021657, Mlig455_067458 | Neo: - |
CHRNB1, CHRNB3 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_021657 {REF} {Length: 2044} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=73.5]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=193, Expect=5e-56]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=189, Expect=1e-54]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=187, Expect=8e-54]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=186, Expect=1e-53]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=179, Expect=5e-51]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=176, Expect=3e-49]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=174, Expect=9e-49]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=346, Expect=9e-116]} {RNA1509_8724} {RNA1310_17144.1, RNA1509_8724} {RNA1509_8724, RNA815_6285} Mlig455_067458 {REF} {Length: 1512} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=43.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=18.7]} {Human: ENSG00000283946, CHRNB1, cholinergic receptor nicotinic beta 1 subunit, [Score=48.1, Expect=7e-06]; ENSG00000170175, CHRNB1, cholinergic receptor nicotinic beta 1 subunit, [Score=48.1, Expect=7e-06]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=47.8, Expect=1e-05]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=47.4, Expect=1e-05]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=46.6, Expect=1e-05]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=96.7, Expect=1e-22]} {RNA1509_8724} {RNA1310_17144.1} {RNA815_6285} |
| 18. | MligTC455_14960 | 53 | 1.09 | Mlig455_000966 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_000966 {REF} {Length: 2233} {NoTransDecoderORF} {RNA1509_41553} {RNA1310_74280} {RNA815_43450} | |
| 19. | MligTC455_15784 | 370 | 7.7 | Mlig455_029287 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_029287 {REF} {Length: 1928} {Pfam: TIR domain [PF13676.8, score=46.2]} {Smed: dd_Smed_v6_13404_0_1, dd_Smed_v6_13404_0_1, [Score=112, Expect=2e-26]} {RNA1509_41551} {RNA1310_16315, RNA1509_41551} {RNA1509_41551, RNA815_7731} | |
| 20. | MligTC455_45726 | 5045 | 105.11 | Mlig455_056717, Mlig455_060302 | Neo: - Age: - Region-enriched R4: 1.349/0.00349 |
NXNL2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_056717 {REF} {Length: 1138} {Pfam: Thioredoxin-like [PF13905.8, score=95.2]; AhpC/TSA family [PF00578.23, score=48.2]; Redoxin [PF08534.12, score=44.5]; Thioredoxin [PF00085.22, score=39.8]; Thioredoxin-like domain [PF13098.8, score=29.9]; Thioredoxin-like [PF13899.8, score=22.0]; Thioredoxin [PF14595.8, score=20.3]} {Human: ENSG00000130045, NXNL2, nucleoredoxin like 2, [RH, Score=85.9, Expect=2e-21]} {Mouse: ENSMUSG00000021396, Nxnl2, nucleoredoxin-like 2, [RH, Score=87.0, Expect=3e-22]} {Celegans: WBGene00021796, Y52E8A.3, [RH, Score=120, Expect=1e-35]} {RNA1509_4074, RNA1509_46636, RNA1509_9736} {RNA1310_41004, RNA1509_4074, RNA1509_46636, RNA1509_9736} {RNA1509_4074, RNA1509_46636, RNA1509_9736, RNA815_22016} Mlig455_060302 {REF} {Length: 1261} {Pfam: Thioredoxin-like [PF13905.8, score=95.5]; AhpC/TSA family [PF00578.23, score=48.5]; Redoxin [PF08534.12, score=44.5]; Thioredoxin [PF00085.22, score=39.7]; Thioredoxin-like domain [PF13098.8, score=30.0]; Thioredoxin-like [PF13899.8, score=22.0]; Thioredoxin [PF14595.8, score=20.2]} {Human: ENSG00000130045, NXNL2, nucleoredoxin like 2, [RH, Score=85.9, Expect=1e-21]} {Mouse: ENSMUSG00000021396, Nxnl2, nucleoredoxin-like 2, [RH, Score=88.2, Expect=1e-22]} {Celegans: WBGene00021796, Y52E8A.3, [RH, Score=123, Expect=1e-36]} {RNA1509_21827, RNA1509_22137, RNA1509_9736} {RNA1310_41004, RNA1509_21827, RNA1509_22137} {RNA1509_21827, RNA1509_22137, RNA815_22016} |
| 21. | MligTC455_44365 | 1412 | 29.41 | Mlig455_002492 | Neo: - Age: logFC(26M/2M)=0.553 |
MYCBPAP | 0.951 | - | - | - | - | - | 0.951 | Mlig455_002492 {REF} {Length: 3081} {Pfam: MYCBP-associated protein family [PF14646.8, score=368.3]} {Human: ENSG00000136449, MYCBPAP, MYCBP associated protein, [RH, Score=280, Expect=2e-80]} {Mouse: ENSMUSG00000039110, Mycbpap, MYCBP associated protein, [RH, Score=276, Expect=5e-79]} {Smed: dd_Smed_v6_11993_0_1, dd_Smed_v6_11993_0_1, [RH, Score=323, Expect=3e-97]} {RNA1509_4206} {RNA1310_3498.3} {RNA815_1306} |